Public recall detail

Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.

2026-07-30

medium
Health products Health product recall
Quick summary

Quick summary: Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.. Reason: Health product recall. Category: Health products. Date: 2026-07-30.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.. Reason: Health product recall. Category: Health products. Date: 2026-07-30.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandLupin Pharma Canada Ltd.
ProductFemyso Mifepristone 200mg / Misoprostol 200 mcg tablet
IssueHealth products - Packaging
Recall classType II
IdentificationRA-82416

Affected products

BrandLupin Pharma Canada Ltd.
ProductFemyso Mifepristone 200 mg / Misoprostol 200 mcg tablet
DIN / NPN / authorizationDIN 02560569
Dosage formKit, Tablet
StrengthMifepristone 200 mg / Misoprostol 200 mcg
LotNR02557A

Issue

Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.

What you should do

  • Verify whether your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesLupin Pharma Canada Limited. 550-1111 rue St-Charles Ouest Longueuil, QC, J4K 5G4
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-82416
Background{}
CompaniesLupin Pharma Canada Limited. 550-1111 rue St-Charles Ouest Longueuil, QC, J4K 5G4
AudiencesGeneral public Healthcare Industry
Source updated2026-07-30

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...